[Roaming through methodology. XXIX. P].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to M D Abràmoff.
Explore the source record for details and available documents.
PURPOSE: To study possible causes of persistent pain in patients who underwent enucleation of the globe and in whom all other noninvasively detectable causes of pain had been ruled out. METHODS: Twenty patients were studied, 10 with intractable pain (score >5 on a 0-to-9 self-reporting pain scale) persisting for more than 6 months after enucleation (for various reasons) and 10 without pain (score <4) at least 6 months after enucleation. Magnetic resonance imaging (MRI) with dynamic color mapping (MRI-DCM) was used to quantify the motion of the optic nerve in millimeters per degree of gaze, 2 to 3 mm behind the implant. Histopathologic study of biopsy specimens was used to verify imaging findings. RESULTS: The optic nerve was attached to the implant in almost all (19/20) patients. On average, the motion was significantly less in patients with persistent intractable pain (0.04 mm/deg) than in patients without pain (0.08 mm/deg; normal orbit, 0.13 mm/deg). A biopsy specimen was available in 5 of 10 patients with persistent pain, and in 4 of those 5, microscopic neuroma was found close to the optic nerve-implant junction. CONCLUSIONS: In the enucleated orbit, the optic nerve is usually attached to the implant and soft tissue motion is decreased. In patients who have persistent pain after enucleation, motion is decreased even more, and a high percentage of microscopic amputation neuromas are found. Increased stiffness of orbital soft tissue and optic nerve attachment after enucleation are detectable using MRI-DCM, and may play a role in susceptible patients in the development of microscopic amputation neuroma and pain.
Orbital soft-tissue motion analysis aids in the localization and diagnosis of orbital disorders. A technique has been developed to objectively quantify and visualize motion in the orbit during gaze. T1-weighted MR volume sequences are acquired during gaze and soft-tissue motion is quantified using optical flow techniques. The flow field is visualized using color-coding: orientation of the flow vector is coded by hue and magnitude by saturation of the pixel. Current clinical circumstances limit MR image acquisition to short sequences and short acquisition times. The effect of these limitations on the performance of optical flow computation has been studied for four representative optical flow algorithms: on short (nine frames) and long (21 frames) simulated sequences of rotation of a magnetic resonance (MR) imaged object, on short measured MR sequences of controlled rotation of the same object and on short MR sequences of motion in the orbit. On the short simulated and motion-controlled sequences, the Lucas and Kanade algorithm showed the best performance with respect to both accuracy and robustness. These motion estimates were accurate to within 20%. Motion in the orbit ranged between 0.05 and 0.25 mm/degree gaze. Color-coding was found to be attractive as a visualization technique, because it shows both magnitude and orientation of all flow vectors without cluttering.
PURPOSE: To investigate both feasibility and clinical potential of magnetic resonance imaging-dynamic color mapping (MRI-DCM) in measuring the motion of soft tissues in the orbit and in the diagnosis of orbital disorders by detecting changes in motion. METHODS: Sequences of MRI scans were acquired (acquisition time, 5 seconds) in a shoot-stop manner, while the patient fixated at a sequence of 13 gaze positions (8 degrees intervals). Motion was quantified off-line (in millimeters per degree of gaze change) using an optical flow algorithm. The motion was displayed in a color-coded image in which color saturation of a pixel shows the displacement and the hue the displacement's orientation. Six healthy volunteers and four patients (two with an orbital mass and two with acrylic ball implant after enucleation) were studied. RESULTS: The technique was found to be clinically feasible. For a gaze change of 1 degrees, orbital tissues moved between 0.0 and 0.25 mm/deg, depending on the type of tissue and location in the orbit. In the patients with an orbital mass, motion of the mass was similar to that of the medial rectus muscle, suggesting disease of muscular origin. In the enucleated orbits, soft tissue motion was decreased. One eye showed attachment of the optic nerve to the implant, which could be verified by biopsy. CONCLUSIONS: MRI-DCM allows noninvasive and quantitative measurement of soft tissue motion and the changes in motion due to pathologic conditions. In cases in which the diagnosis of a tumor in the apex is in doubt, it may reduce the need for biopsy. In contrast to static computed tomographic (CT) scans and MRIs, it can differentiate between juxtaposition and continuity and may be a new and promising tool in the differential diagnosis of intraorbital lesions.